Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBS Bio-Platforms, formerly known as Canadian Bio-Systems, is a leading biotechnology company focused on the development and commercialization of advanced enzyme and animal nutrition solutions. Headquartered in Calgary, the company specializes in bio-based products including feed enzymes, yeast carbohydrates, and probiotics designed to enhance livestock performance and welfare. Their flagship Multi-Carbohydrase technology allows for the breakdown of complex dietary components, optimizing nutrient availability across various species such as poultry, swine, and ruminants. In late 2022, the company was acquired by Adisseo, a global leader in nutritional additives, to bolster its specialty ingredients portfolio. CBS Bio-Platforms continues to operate as a center of excellence for enzyme research and sustainable agricultural solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Bio-Systems.